Literature DB >> 23786430

Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension.

Murat Sunbul1, Fethullah Gerin, Erdal Durmus, Tarik Kivrak, Ibrahim Sari, Kursat Tigen, Altug Cincin.   

Abstract

BACKGROUND: Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) are associated with worse outcome in various diseases. Non-dipping blood pressure pattern is associated with higher cardiovascular mortality. The aim of this study was to explore the association between NLR and PLR in patients with dipper versus non-dipper hypertension.
METHODS: The study included 166 patients with hypertension. Eighty-three patients (40 male, mean age: 49.1 ± 10.5 years) had dipper hypertension, while 83 patients (41 male, mean age: 52.3 ± 12.7 years) had non-dipper hypertension.
RESULTS: Baseline demographic characteristics were similar in both groups. Patients with non-dipper hypertension had significantly higher NLR compared to dipper hypertension (2.3 ± 0.9 versus 1.8 ± 0.5, p < 0.001). Patients with non-dipper hypertension had significantly higher PLR compared to dipper hypertension (117.7 ± 35.2 versus 100.9 ± 30.5, p = 0.001). In univariate analysis, hyperlipidemia, smoking, presence of diabetes, PLR more than 107 and NLR more than 1.89 were among predictors of dipper and non-dipper status. In logistic regression analyses, only hyperlipidemia (odds ratio: 2.96, CI: 1.22-7.13) and PLR more than 107 (odds ratio: 2.62, CI: 1.13-6.06) were independent predictors of dipper and non-dipper status. A PLR of 107 or higher predicted non-dipper status with a sensitivity of 66.3% and specificity of 68.7%.
CONCLUSION: We demonstrated that patients with non-dipper hypertension had significantly higher NLR and PLR compared to dipper hypertension, which has not been reported previously. Moreover PLR more than 107 but not NLR was independent predictor of non-dipper status.

Entities:  

Keywords:  Neutrophil to lymphocyte ratio; dipper; hypertension; non-dipper; platelet to lymphocyte ratio

Mesh:

Year:  2013        PMID: 23786430     DOI: 10.3109/10641963.2013.804547

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  55 in total

1.  Do circulating blood cell types correlate with modifiable risk factors and outcomes in patients with acute coronary syndrome (ACS)?

Authors:  Kamal H Sharma; Komal H Shah; Iva Patel; Alap K Patel; Subhash Chaudhari
Journal:  Indian Heart J       Date:  2015-08-06

2.  Assessment of Prognostic Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Patients with Pulmonary Embolism.

Authors:  Mehmet Baran Karataş; Göktürk İpek; Tolga Onuk; Barış Güngör; Gündüz Durmuş; Yiğit Çanga; Yasin Çakıllı; Osman Bolca
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

3.  The relationship between inflammatory marker levels and pulmonary tuberculosis severity.

Authors:  Ozlem Abakay; Abdurrahman Abakay; Hadice Selimoglu Sen; Abdullah C Tanrikulu
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

4.  Platelet-to-lymphocyte ratio: a prognostic factor for patients with advanced hepatocellular carcinoma?

Authors:  Xiao-cai Tian; Fu-ren Zeng; De-hua Wu
Journal:  Tumour Biol       Date:  2015-05-30

5.  Assessment of arterial stiffness and cardiovascular hemodynamics by oscillometric method in psoriasis patients with normal cardiac functions.

Authors:  Murat Sunbul; Dilek Seckin; Erdal Durmus; Zuleyha Ozgen; Mehmet Bozbay; Ayfer Bozbay; Tarik Kivrak; Mustafa Oguz; Ibrahim Sari; Tulin Ergun; Mehmet Agirbasli
Journal:  Heart Vessels       Date:  2014-03-15       Impact factor: 2.037

6.  Importance of laboratory parameters in patients with obstructive sleep apnea and their relationship with cardiovascular diseases.

Authors:  Tulay Kıvanc; Sevsen Kulaksızoglu; Huseyin Lakadamyalı; Fusun Eyuboglu
Journal:  J Clin Lab Anal       Date:  2017-03-27       Impact factor: 2.352

7.  The platelet-to-lymphocyte ratio as an inflammation marker in non-dipper hypertensive patients.

Authors:  N Bayrakci; N Ozkayar; F Akyel; I Ates; S Akyel; F Dede
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

8.  Platelet to lymphocyte ratio in acute aortic dissection.

Authors:  Eftihia Sbarouni; Panagiota Georgiadou; Elias Kosmas; Antonis Analitis; Vassilis Voudris
Journal:  J Clin Lab Anal       Date:  2018-03-30       Impact factor: 2.352

9.  Platelet to lymphocyte ratio is associated with the severity of coronary artery disease and clinical outcomes of percutaneous coronary intervention in the Chinese Han population.

Authors:  Dong Zhou; Guangyao Wang; Yan Fan; Zhaofei Wan; Xiaojun Liu
Journal:  Exp Ther Med       Date:  2016-12-22       Impact factor: 2.447

10.  Platelet-lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome.

Authors:  Handan Inonu Koseoglu; Fatih Altunkas; Asiye Kanbay; Sibel Doruk; Ilker Etikan; Osman Demir
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.